Predictors of disease progression in patients with CKD

Slides:

Advertisements

Similar presentations

1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.

Advertisements

Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.

6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.

Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.

What are the main benefits of BRAF inhibitors in metastatic melanoma?

HIV/renal studies (CHIC) Baseline renal function as predictor of HIV/renal disease progression –Death, opportunistic infection –Severe chronic kidney disease.

Renal damage occurs in 1 out of 4 hypertensives Adapted from Leoncini et al. J Hypertens. 2008;26:

ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)

Hsia J et al. J Am Coll Cardiol 2011;57: Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:

1 Antonio Bellasi, MD Medical manager Genzyme, Italy Chronic Kidney Disease-Mineral Bone Disorders (CKD-MBD)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes Featured Article: Andrzej S. Krolewski, M.D., Ph.D., James H. Warram,

Updates in Diabetic Nephropathy Rodica Pop-Busui, M.D., Ph.D Division of Metabolism, Endocrinology and Diabetes Michigan Comprehensive Diabetes Center.

ESTIMATION OF eGFR IN CHILDREN WITH NORMAL OR SLIGHTLY IMPAIRED RENAL FUNCTION- COMPARISON OF THREE FORMULAS Katarzyna Jobs, Anna Jung, Marianna Lichosik,

© 2016 S. Karger AG, Basel. All rights reserved Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency.

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

Baseline Characteristics of the Patients Part I

Melody Sherwood, Peter A McCullough The Lancet Global Health

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

The MDRD Study.

by Qi Sun, Monik C. Jiménez, Mary K. Townsend, Eric B. Rimm, JoAnn E

TNT: Baseline and final LDL cholesterol levels

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

Figure 4 Interplay between acute kidney injury (AKI),

Chronic Kidney Disease in HIV Infection: An Urban Epidemic

SAVE: Risk of total mortality associated with reduced kidney function

Kuwabara et al. Am J Nephrol 2017;45: (DOI: / )

Progression of CKD with ADMA levels above and below the median

Outcomes with trisodium citrate 30% vs heparin as catheter-locking solution (all catheters) in patients on hemodialysis Variable TSC, n (%) Heparin, n.

Bhandari et al. Am J Nephrol 2017;45: (DOI: / )

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Bushinsky et al. Am J Nephrol 2016;44: (DOI: / )

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Management of hypertension in patients with chronic kidney disease

Mean eGFR among survivors after CABG surgery vs all-cause deaths

Section 2: AKI Definition

TNT post hoc analysis: Improvement between baseline and final visit in estimated GFR by treatment group End point 10-mg atorvastatin 80-mg atorvastatin.

CHOICE study: Relative hazard of ASCVD events by baseline levels of Lp(a), LMW ApoA isoforms, and LMW ApoA isoforms with high Lp(a) vs high-molecular-weight.

Figure 4 Model of changes in the serum levels

Association between highest tertile for homocysteine and mortality

Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients Sprague et al.

Health ABC: Mortality risk by quintile of cystatin C

Melody Sherwood, Peter A McCullough The Lancet Global Health

CREATE: Baseline values

Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina O'Shaughnessy et al. Am J Nephrol 2017;45:

Figure 3 Serum phosphate level is associated with

Chapter 2: Use of iron to treat anemia in CKD

CKD cohort Non-CKD cohort Test Entire cohort, n=24 778

Forest plot displaying the effect estimates comparing azithromycin and placebo treatment in subgroups defined by above (>0.39 ng·mL−1) or below (

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Patient characteristics: American vs Canadian transplant patients

Baseline Characteristics of the Subjects

Nat. Rev. Cardiol. doi: /nrcardio

The severity of fatigue over 8 years of disease in early rheumatoid arthritis patients. The severity of fatigue over 8 years of disease in early rheumatoid.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.

Patient Disposition James A. de Lemos et al. JAMA 2004; 292:

Nowak et al. Am J Nephrol 2016;44: (DOI: / )

Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:

Cost Effectiveness of Intraoperative MRI for Treatment of High-Grade Gliomas Compared with neuronavigation systems, intraoperative MRI reliably maximizes.

Targeting Immunity in End-Stage Renal Disease

Incidence of contrast-induced nephropathy in patients with CKD, normal kidney function and all patients. Incidence of contrast-induced nephropathy in patients.

Increase of physical activity over time associated with lower HF risk

Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.

Plots of average estimated and measured GFR vs

Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier plots. Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier.

Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.

Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:

Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

Predictors of disease progression in patients with CKD Factor Hazard ratio (95% CI) p Baseline estimated GFR (for each increment of 10 mL/min per 1.73 m2) 0.714 (0.627–0.814) <0.0001 Serum apoA-IV concentrations (for each increment of 1 mg/dL) 1.062 (1.018–1.108) 0.006 Boes E et al. J Am Soc Nephrol; published online before print December 28, 2005.

Time to progression in patients above and below the median cut point for apoA-IV levels End point ApoA-IV levels above the median ApoA-IV levels below the median Time to progression (mo) 53.7 (47.6–59.8) 70.0 (64.6–75.4) Boes E et al. J Am Soc Nephrol; published online before print December 28, 2005.